Contraceptive Efficacy Study of Ovaprene
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Daré Bioscience, Inc.
- Study ID
- NCT06127199
- Status
- Recruiting
Conditions
- Contraception
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Accepted
Interventions
- Ovaprene — DEVICENon-hormonal intravaginal ring
Study Details
This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.
Key Dates
- Start date
- Dec 19, 2023
- Status verified
- May 2026
- Primary completion
- Apr 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 656 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: Ovaprene
Primary Outcome Measure
Determination of pregnancy rate [ Time Frame: 12 months ]
Central Contacts
- Christine Mauck, MDwww.ovaprenestudy.com
- Jessica Hathewaywww.ovaprenestudy.com
Locations (27)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Precision Trials AZ | Phoenix | Arizona | 85032 | Valerie Sorkin-Wells, MD (PRINCIPAL_INVESTIGATOR) |
| MomDoc Women's Health Research | Scottsdale | Arizona | 85251 | - |
| Del Sol Research Management, LLC | Tucson | Arizona | 85715 | C. Paige Brainard, MD (PRINCIPAL_INVESTIGATOR) |
| Essential Health Access (Berkeley) | Berkeley | California | 94710 | - |
| Essential Access Health | Los Angeles | California | 90010 | - |
| Amicis Research Center | Newhall | California | 91321 | - |
| University of California at Davis | Sacramento | California | 95817 | - |
| University of California, San Francisco | San Francisco | California | 94143 | - |
| University of Colorado Denver | Aurora | Colorado | 80045 | - |
| Emory University | Atlanta | Georgia | 30322 | - |
| University of Hawaii | Honolulu | Hawaii | 96826 | - |
| Praetorian Pharmaceutical Research, LLC | Marrero | Louisiana | 70072 | - |
| The Johns Hopkins University | Baltimore | Maryland | 21224 | - |
| Boston Medical Center | Boston | Massachusetts | 02118 | - |
| Washington University | St Louis | Missouri | 63110 | - |
| Rutgers Medical Center | Newark | New Jersey | 07103 | - |
| Columbia University | New York | New York | 10032 | - |
| Einstein College of Medicine | The Bronx | New York | 10461 | - |
| Carolina Women's Research and Wellness Center | Durham | North Carolina | 27713 | - |
| University of Cincinnati | Cincinnati | Ohio | 45267 | - |
| Case Western | Cleveland | Ohio | 44106 | - |
| Oregon Health and Science University | Portland | Oregon | 97239 | - |
| University of Pennsylvania Penn Obstetric Gynecology Associates | Philadelphia | Pennsylvania | 19104 | - |
| Magee-Women's Hospital | Pittsburgh | Pennsylvania | 15213 | - |
| University of Utah | Salt Lake City | Utah | 84132 | - |
| Eastern Virginia Medical School | Norfolk | Virginia | 23507 | - |
| Seattle Clinical Research Center | Seattle | Washington | 98104 | Ashley Fuller, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Phoenix, AZ
Related Studies
- Evaluation of the Efficacy, Safety, and Tolerability of LevoCeptPHASE3 · Not Yet Recruiting · Sebela Women's Health Inc. · Berkeley, California
- Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum PeriodRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Etonogestrel Implant as Emergency ContraceptionPHASE4 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day StartPHASE4 · Recruiting · University of Utah · San Jose, California